logo

Fulcrum Therapeutics (FULC)



Trade FULC now with
  Date
  Headline
10/4/2019 4:54:28 AM Fulcrum Therapeutics Announced Results Of Phase 1 Clinical Trial Of Losmapimod In FSHD
8/19/2019 7:09:31 AM Fulcrum Therapeutics Initiates ReDUX4, A Phase 2b Clinical Trial Of Losmapimod
7/17/2019 8:55:59 PM Fulcrum Therapeutics Prices IPO Of 4.50 Mln Shares At $16.00/shr
7/13/2019 1:10:19 PM Biotech IPOs For The Week Ahead
  
 
>